Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines
暂无分享，去创建一个
U. Dafni | E. de Vries | M. Strijbos | T. Amaral | G. Zarkavelis | N. Cherny | N. Latino | G. Pentheroudakis | A. Amylidi | P. Zygoura | R. Giuliani | F. Lordick | Y. Metaxas | F. Pignatti | K. Jordan | C. Verbaanderd | E.G.E. de Vries | M. Galotti